Yuta Ito

9PUBLICATIONS
96CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedLiquid biopsiesPredictive and prognostic markersSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 20, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.

|Jul 17, 2025
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis.

Kentaro Yamaguchi, Junji Koya, Kota Mizuno

|May 02, 2025
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma.

Yuta Ito, Joji Shimono, Keisuke Kawamoto

|Oct 22, 2024
Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targets.

Junji Koya, Tomohiko Tanigawa, Kota Mizuno

|Apr 24, 2024
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.

Yuta Ito, Amira Marouf, Yasunori Kogure

|Mar 01, 2024
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.

Yasunori Kogure, Hiroshi Handa, Yuta Ito

Pageof 2

Frequent Collaborators

7 joint publications

Yasunori Kogure

7 joint publications

Keisuke Kataoka

5 joint publications

Yuki Saito

4 joint publications

Junji Koya